Tumor tissue levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and outcome following adjuvant chemotherapy in premenopausal lymph node-positive breast cancer patients: A retrospective study

BACKGROUND: We have previously demonstrated that high tumor tissue levels of TIMP-1 are associated with no or limited clinical benefit from chemotherapy with CMF and anthracyclines in metastatic breast cancer patients. Here, we extend our investigations to the adjuvant setting studying outcome after...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Schrohl, Anne-Sofie, Look, Maxime P, Meijer-van Gelder, Marion E, Foekens, John A, Brünner, Nils
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2754488/
https://ncbi.nlm.nih.gov/pubmed/19744322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-9-322
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares